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In rabbits which are heterogeneous with respect to antigenic determinants on
serum immunoglobulins (Ig), prenatal or neonatal exposure to antibodies specific
for one allelic allotype leads to a long-lasting suppression of that type with
compensatory production of the alternate allelic product. This phenomenon,
called allotype suppression, was first described by Dray in 1962 (1). Although
many studies since then have amply verified and further characterized Dray's
original observations (reviewed by Mage in reference 2), the mechanism of
suppression remains obscure. By using specific antiallotype sera it has been
possible to identify b locus determinants on T2-neutralizing antibodies formed
by spleen cells ofheterozygous rabbits in vitro and to demonstratethat cells from
b4b5 rabbits which were deficient in their ability to produce b4 Ig because of
exposure to anti-b4 in utero formed anti-T2 antibodies which appeared to be
entirely of the nonsuppressed type, namely, b5 (3). However, when such cells
were cultured in the presence of anti-b5 serum made in b4 rabbits, b5 anti-T2
production was suppressed, while highly significant amounts ofb4 anti-T2 were
formed, indicating that the anti-b5 serum had caused release of the mechanism
responsible for allotype suppression.
In the present study, the more general applicability of this phenomenon has
been verified by culturing the spleen cells of b4-suppressed b4b6 rabbits with b4
anti-b6 serum. Results entirely analogous to those previously observed with the
b4b5 system are reported. A further extension ofthe experimental conditions for
bringing about the reversal of b4 suppression by using other rabbit antisera
specific for the nonsuppressed type has revealed the participation oftwo factors
in this process: antibody activity against the nonsuppressed allotype and normal
b4 Ig.
Materials and Methods
Animals.
￿
Rabbits of known a and b locus allotypes were bred at this Institute.
Determination of Ig with Specific Allotypic Markers in Serum.
￿
The method for determining
serum levels of Ig with specific allotypic markers using thetechnique of hernagglutination-inhibition
(HI)' has been described in a previous publication (3) .
* This work was supported in part by grant AI-11940 from the National Institutes of Health.
`Abbreviations used in this paper: FCS, fetal calf serum; HI,hemagglutination-inhibition; MEM,
minimal essential medium ; NT,,, 30% neutralization titer; PPN, phage protein nitrogen; S-T2,
solubilized T2 phage.
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Preparation of Antiallotype Sera. Antisera specific for the b5 marker were prepared by
immunizing alal/b4b4 or a2a2/b6b6 rabbits with alal/b5b5 or a2a2/b5b5 Ig, respectively. Anti-b6
serum wasobtained by immunization of a3a3/b4b4 or a2a2/b5b5 rabbits with a3a3/b6b6 or a2a2/b6b6
Ig, respectively. Details of the immunization procedures have been given previously (3) . The
specificity of each serum was determined by hemagglutination and HI tests against a large number of
sera from rabbits of known allotypes. Thewell knowncross-reaction between b5 andb6 determinants
was observed consistently when antisera were raised in b4 rabbits. However, no traceofcross-reaction
between b4 and either b5 or b6 was ever seen . All sera were heated at 56°C for 30 min before use. Sera
to be added to cultures were sterilized by passagethrough Millipore filters of0.45,um pore diameter.
Culture Methods.
￿
Spleen cells from unprimed rabbits were cultured according to the technique
of Mishell and Dutton (4) with the modifications described by Meiss andFishman (5) and by Adler
(3) . Twolots of fetal calf serum (FCS) were used throughout these experiments (lots no. 81689 andno.
82082, Microbiological Associates, Bethesda, Md.) and were of equivalent efficacy in supporting the
response to solubilized T2 phage (S-T2) preparations. Antiallotype serum was diluted in Eagle's
minimum essential medium (MEM) and added at culture initiation in avol of 0.03 ml to each culture
consisting of 2 x 10' nucleated spleen cells . After 1 h of incubation under tissue culture conditions,
S-T2 (0.2 ng phage protein nitrogen [PPN]) in a vol of0.04 ml, and 0.05 ml ofFCS were added to each
1 ml culture. Experiments were terminated at the end of 4 or 5 days, and the supernatant fluids,
clarified by centrifugation, were stored at -20°C for assays of T2-neutralizing activity.
Neutralization Assays.
￿
The procedure used for determining the highest dilution of tissue culture
fluid capable of neutralizing 30% of a test dose of T2 phage (NT,.), using amplification by specific
antiallotype serum, was exactly as outlined in a previous report (3) . Except when otherwise
designated, each experimental group consisted of three identically treated cultures. Thereproducibil-
ity of the response to S-T2 by replicate cultures and the significance of neutralizing activities
obtained have been described in previous publications from this laboratory (3, 6).
Results
Effect of Anti-b6 Serum made in b4 Rabbits on the Responses of Spleen Cells
from b4-Suppressed b4b6 Rabbits to S-T2. A series of experiments was
undertaken in an effort to demonstrate that the release from allotype suppression
in vitro reported previously (3) could be observed using a different combination
of b locus specificities. For this purpose homozygous b6 female rabbits were
immunized against b4 Ig and then bred with b4 males. The resulting b4b6
offspring were first bled at 8 wk of age and their sera assessed for Ig with the b4
and b6 markers. At that age, b4 was usually below the level of detectability (less
than 2 ug per ml), and b6 Ig levels were elevated in comparison to normal b4b6
rabbits of the same age. At ages varying from 21/2 to 8 mo the spleens of these
b4-suppressed b4b6 rabbits were used to establish cultures to which decreasing
amounts of b4 anti-b6 serum, diluted in MEM, were added. An optimal
immunogenic dose of S-T2 (0.2 ng PPN) and FCS (5% of the culture volume)
were added after 1 h of incubation . Each experiment was terminated after 4 or 5
days, and the tissue culture fluids were assayed for anti-T2 activity with the b4
and b6 specificities by using anti-b4 or anti-b6 serum as an amplifying reagent in
the neutralization assay. Table I illustrates the results obtained in three such
experiments. The ratio of b6 to b4 Ig in the serum at the time of sacrifice
indicates the relative degree ofb4 suppression. Normal b4b6 rabbits have serum
b6/b4 ratios of 0.5-1.0. In each instance, no anti-T2 activity attributable to b4
was formed in the control cultures without anti-b6 serum. However, in the
presence of anti-b6 serum there was a proportional inhibition of b6 anti-T2
expression with the concomitant generation of b4 anti-T2 activity. Similar
results were obtained in experiments with the spleen cells of four other334
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TABLE I
Effect of b4 Anti-b6 Serum on the Responses of b4-Suppressed
b4b6 Spleen Cells to S-T2
*Serum obtained on the day of sacrifice .
$Each determination represents the mean of triplicate cultures.
§The lowest dilution tested was 1:4, and <4 indicate no significant neu-
tralization at that dilution.
b4-suppressedb4b6 rabbits not shown here. In some cases, an optimal dose effect
in the suppression-releasing activity of anti-b6 serum was observed, as is seen
here with the cells of rabbit D-232 and to a lesser extent D-285. This seemed to be
a property of the cells rather than of the releasing antiserum. With spleen cells
from highly suppressed rabbits (b6/b4 >300) it was usually found that the
amount of b4 anti-b6 serum that would bring about release was rather critical, as
seen with rabbit D-232. However, reversal of b4 suppression also did not occur in
the presence of higher concentrations of anti-b6 serum on some occasions when
less well-suppressed donors were used, e.g., D-285 in Table 1.
Effect of b6 Anti-b5 Serum on the Responses of b4-Suppressed b4b5 Spleen
Cells to S-T2. In an earlier publication, spleen cells of b4-suppressed b4b5
rabbits were shown to produce anti-T2 neutralizing antibodies having the b4
marker as a result of treatment with anti-b5 serum made in b4 rabbits (3). In the
previous section, analogous results were reported when cells from b4-suppressed
b4b6 rabbits were cultured in the presence of anti-b6 serum taken from b4
rabbits. Experiments were now undertaken to determine if anti-b5 serum made
in rabbits of a type other than b4 would be effective in bringing about release
from b4 suppression in b4b5 cells. Table 11 presents data exemplifying theresults
Spleen
donor
(age in
months)
b6/b4
Ratio
in
serum*
b4 Anti-b6
serum added
to culture
1/NT,a$
b4
Anti-T2:
b6
AI
D-232 >360 30 <4§ <4
(3 mo) 12 <4 <4
6 <4 <4
3 16-32 16-32
0 <4 128-256
D-239 144 30 32-64 <4
(4.5 mo) 12 32-64 <4
6 32-64 <4
3 16-32 8-16
1.5 8 32-64
0 <4 64-128
D-285 15 30 <4 <4
(4 mo) 12 64-128 <4
6 32-64 4-8
3 <4 8
0 <4 16-32LOUISE T. ADLER AND FRANK L. ADLER
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TABLE II
Effect of b6 Anti-b5 Serum on the Responses of b4-Suppressed
b4b5 Spleen Cells to S-T2
* Serum obtained on the day of sacrifice.
$ Each determination is based on the mean of three identical cultures.
obtained when spleen cells of such animals were incubated with anti-b5 serum
made in rabbits of allotype b6. Although such sera significantly depressed the b5
anti-T2 responses of these cells, no release from b4 suppression was seen except
with the cells of donor D-54. This rabbit appeared to be poorly suppressed with
regard to b4 at the time of sacrifice, as indicated by the low serum b5/b4 ratio of
15. Of a total of nine b4-suppressed b4b5 rabbits tested in this manner with three
lots of b6 anti-b5 serum, only two (including D-54) exhibited low titers of b4
anti-T2activity . The second rabbit ofthis group had a b5/b4ratioof 5.
Effect of b5 Anti-b6 Serum on the Responses of b4-Suppressed b4b6 Spleen
Cells to S-T2. In a parallel series of experiments, cells of b4-suppressed b4b6
rabbits were treated with anti-b6 serum made in b5 rabbits. The results obtained
in four out of a total of six such experiments are given in Table III. It can be seen
that with cells from two well-suppressed rabbits (D-234 and D-239), no escape
from b4 suppression occurred with any concentration of b5 anti-b6 serum tested.
However, D-240 and D-250 (with b6/b4 ratios of 36 and 30, respectively) formed
low but significant amounts of b4 anti-T2 in the presence of the higher
concentrations of anti-b6 serum used. The two remaining donors not represented
in this table had b6/b4 ratios of 51 and 60 at time of sacrifice and their spleen
cells exhibited no escape from allotype suppression when cultured with b5
anti-b6 serum.
Reversal of b4 Suppression by a Mixture of Normal b4 Serum with b5 Anti-b6
or b6 Anti-b5 Serum.
￿
The observations made up to this point, i.e., that (a) b4
Spleen
donor
(age in
months)
b5/b4
Ratio
in
serum*
b6-Anti-b5
serum added
to culture
1/NT,o$
b4
Anti-T2 :
b5
Al
D-196 320 30 <4 8-16
(3 mo) 12 <4 32-64
6 <4 32-64
3 <4 32-64
0 <4 128-256
D-192 82 30 <4 <16
(2.5 mo) 12 <4 32-64
6 <4 64-128
0 <4 128
D-54 15 30 4-8 <4
(4 mo) 12 4-8 <4
6 <4 <4
3 <4 8
0 <4 16-32336
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TABLE III
Effect of b5 Anti-b6 Serum on the Responses of b4-Suppressed
b4b6 Spleen Cells to S-T2
*Serum obtained on day of sacrifice.
tEach determination represents the mean titerof threeidentical cultures.
anti-b5 or b4 anti-b6 serum readily brought about a reversal of b4 suppression in
spleen cells from b4-suppressed b4b5 or b4b6 animals, respectively, and that (b)
b6 anti-b5 or b5 anti-b6 serum was ineffective with the same respective cell types
unless the rabbits were at the time of sacrifice well advanced in their spontaneous
escape from suppression, suggested a possible role for normal serum b4 Ig in this
phenomenon . Therefore, experiments were undertaken to determine if the cells of
b4-suppressed b4b5 or b4b6 rabbits would form b4 anti-T2 antibodies when
treated with a mixture of normal b4 serum and b6 anti-b5 or b5 anti-b6 serum,
respectively . Representative experiments illustrating these two sets of conditions
are shown in Tables IV and V. It can be seen from Table IV that the addition of
normal b4 serum together with anti-b5 serum from a b6 rabbit to cultures of
spleen cells from a b4-suppressed b4b5 rabbit resulted in the formation of T2
neutralizing antibodies with b4 specificity. No b4 anti-T2 activity was demon-
strable in fluids obtained from cultures incubated with the b6 anti-b5 serum
alone. Normal b4 serum had no effect on the responses of b4-suppressed cells, as
has been observed repeatedly in the course of these studies (3). The data
presented in Table V demonstrate that a mixture of normal b4 serum and b5
anti-b6 serum could bring about a reversal of b4 suppression in b4-suppressed
b4b6 cells, while the anti-b5 serum alone was completely ineffective .
Spleen
donor
(age in
months)
b6/b4
Ratio
in
serum*
b5 Anti-b6
serumadded
to culture
1/NT,o$
b4
Anti-T2:
b6
Al
D-234 360 30 <4 <4
(5.5 mo) 12 <4 <4
6 <4 4
3 <4 8
1.5 <4 8-16
0 <4 64-128
D-239 144 30 <4 <4
(4.5 mo) 12 <4 <4
6 <4 16-32
3 <4 32-64
0 <4 64-128
D-240 36 6 4 8-16
(5 mo) 3 <4 16-32
1.5 <4 32-64
0 <4 32-64
D-250 30 30 8 <4
(6 mo) 0 <4 32-64LOUISE T. ADLER AND FRANK L. ADLER
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TABLE IV
Effect ofa Mixture of b6Anti-b5 Serum and Normal b4 Serum on
the Responses of b4-Suppressed b4b5 Spleen Cells to S-T2
Spleen cellsused were from a b4-suppressedb4b5 rabbit (age 4 mo) whose
serum b6/b4 ratio of 25 on the day of sacrifice.
*Mean of triplicate cultures.
TABLE V
Effect ofa Mixture of b5 Anti-b6 Serum and Normal b4 Serum on
the Responses of b4-Suppressed b4b6 Spleen Cells to S-T2
Spleen cells used were from a 5-mo old b4-suppressed b4b6 rabbit whose
serum b6/b4 ratio at the time of sacrifice was 51.
*Mean of triplicate cultures.
Table VI presents additional data which indicate a dose effect of the normal b4
serum. No b4 anti-T2 production occurred in the presence of any concentration of
the b5 anti-b6 serum tested, although there was almost complete suppression of
the b6 anti-T2 response. The admixture of at least 3jA1 of normal b4 serum in this
experiment was required to bring about detectable reversal of b4 suppression,
and significantly more b4 anti-T2 activity was formed when 30 m1 of normal b4
b5 Anti-b6
serum/culture
b4 Normal
serum/culture
VNT,o*
b4
Anti-T2:
b6
Jul pl
30 0 <4 <4
12 0 <4 <4
6 0 <4 <4
30 30 32 <4
12 30 64 <4
6 30 32-64 <4
30 <4 128
b6 Anti-b5
serum/culture
b4 Normal
serum/culture b4
VNT9o*
b5
Anti-T2:
Jul gal
30 0 <4 <4
12 0 <4 ND
6 0 <4 8-16
3 0 <4 16
30 30 <8 <4
12 30 16 8
6 30 8-16 8-16
3 30 <4 16
0 30 <4 64338
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TABLE VI
Release from b4 Suppression in b4b6 Spleen Cells by Mixtures of
b5 Anti-b6 Serum and Normal b4 Serum
Spleen cells were those of a 5-mo old b4-suppressed b4b6 rabbit with a
serum b61b4 ratio of 60.
* Mean of triplicate cultures .
serum was present. In this experiment release from b4 suppression occurred as a
result of treatment with 12 ul of anti-b6 serum per culture, but not with 30 Al.
The occurrence of such optimal zones has been noted in an earlier section.
Findings such as those just cited suggested that in assaying the potency of b4
anti-b5 or b4 anti-b6 sera in releasing b4 suppression in b4b5 or b4b6 rabbits
suppressed with regard to b4 production (ref. 3 and Table I), normal b4 Ig in the
antiallotype serum might be a limiting factor. This possibility was tested using
protocols such as that presented in Table VII. In this experiment, incorporation
into the culture medium of as little as 1.5 Al of the b4 anti-b6 serum resulted in
the production of significant anti-T2 activity with b4 specificity (1/NT3o of 4-8) .
When the same range of b4 anti-b6 serum concentrations was tested together
with 6 or 12 Al of normal b4 serum, as little as 0.4ul of the antiallotype serum was
sufficient to provoke a significant b4 anti-T2 response . Moreover, the b4 anti-T2
titers are seen to be significantly higher with 12 Al than with 6 ul of normal b4
serum. The degree of depression of the b5 anti-T2 response is independent ofthe
presence of normal b4 serum.
Discussion
The demonstration of release from b4 suppression in b4b6 spleen cells through
their exposure to antibodies specific for b6 strengthens the significance of the
previously reported release in b4b5 cells that was mediated by anti-b5 (3). The
b5 Anti-b6
serum/culture
b4 Normal
serum/culture b4
VNT,o*
b6
Anti-T2:
Al Jul
30 0 <4 <4
12 0 <4 <4
0 0 <4 16-32
30 0.3 <4 <4
12 0.3 <4 <4
0 0.3 <4 32-64
30 3 <4 <4
12 3 8 4-8
0 3 <4 32
30 30 <4 <4
12 30 16-32 <4
0 30 <4 32-64LOUISE T . ADLER AND FRANK L. ADLER
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TABLE VII
Nonantibody b4 Ig as a Limiting Factor in Release from b4
Suppression in b4b6 Spleen Cells Treatedwith b4 Anti-b6Serum
b4 Anti-b6
￿
b4 Normal
Spleen cellsused were from ab4-suppressed b4b6 rabbit (age 8mo)with a
serum b6/b4 ratio of 25 on the day of sacrifice.
* Mean of duplicate cultures.
observation that antiallotype serum which itself has the same allotypic specific-
ity as the suppressed type, namely b4, is far more efficient in releasing allotype
suppression than antisera made in rabbits ofother allotypes (b5 or b6) appears to
reveal a significant aspect of the mechanism ofallotype suppression. Treatment
of cells from b4-suppressed b4b5 orb4b6 rabbits with anti-b5 oranti-b6 sera made
in b6 orb5 animals, respectively was generally seen not to result in a release from
suppression. These observations suggested that b4 Ig plays an important role
in release from b4 suppression, but they did not show whether it was some pre-
culiarity in the b4 anti-b5 or b4 anti-b6 that was directly related to its antibody
function or whether it was the allotypic specificity ofsuch an antiserum that ac-
counted for its effectiveness. Experiments such as those shown in Tables IV,
V, and VI demonstrated that the addition ofnormal b4 serum to b6 anti-b5 or b5
anti-b6 serum rendered it as effective as b4 antiserum in causing release from
allotype suppression. Such experiments indicate therefore that nonantibody
b4Ig molecules in b4 antiallotype sera are one ofthe two factors involved in over-
coming allotype suppression in our in vitro system, the other being antibody
activity against the nonsuppressed type. Inspection of data shown in Tables II
and III shows that anti-b5 or anti-b6 sera other than those made in b4 rabbits
serum/culture
Jul
serum/culture
Al
b4 b6
Anti-T2:
6 0 16-32 <4
3 0 8-16 <4
1.5 0 4-8 <4
0.8 0 <4 4
0.4 0 <4 4-8
6 6 16-32 <4
3 6 8-16 <4
1.5 6 16 <4
0.8 6 8-16 4
0.4 6 4-8 4-8
6 12 16-32 <4
3 12 16-32 <4
1.5 12 16-32 <4
0.8 12 16-32 4-8
0.4 12 8-16 4-8
0 0 <4 8-16340
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were occasionally effective in bringing about release from b4 suppression, but
only in cultures of spleen cells from b4-suppressed rabbits that were well on
their way to recovery. Cultured cells from poorly suppressed rabbits, such as
D-54 in Table II, and D-240 and D-250 in Table III form small amounts of b4
Ig which can be detected by hemagglutination-inhibition, although the anti-
T2 fraction of Ig with the b4 marker is usually too small to be measurable in
the neutralization assay. For example, 4-day culture fluids from cells of rabbit
D-250 in Table III contained approximately 5 ug of b4 Ig per ml. The presence of
small quantities of spontaneously formed b4 Ig might be enough to implement
the action of b6 anti-b5 or b5 anti-b6 serum and thus facilitate the formation of
low levels of b4 anti-T2 activity by cells of b4-suppressed rabbits already
advanced in escape from suppression.'
The essential participation of nonantibody Ig having the same b locus
determinant as the suppressed type was further confirmed in studiessuch as that
presented in Table VII, which clearly showed that b4 Ig is a limiting factor when
the suppression-releasing activity of b4 anti-b6 serum on b4-suppressed b4b6
cells is assessed . Normal b4 serum alone has been shown repeatedly throughout
the course of these investigations not to cause reversal of b4 suppression in spleen
cells of rabbits that were well suppressed with respect to b4. Thus, the event
reported here differs from the neutralization of allotype suppression in vivo which
can be brought about only early in the life of the suppressed rabbit, either by
injections of the suppressed Ig type or by putting the baby rabbits to nurse on
foster mothers having that Ig type (7-10) . This phenomenon has been attributed
to neutralization of the antiallotypic antibodies which are the initiators of the
chronically suppressed state and are still present in the young rabbit . Interest-
ingly, however, Catty et al. (9) have noted that in b4b6 rabbits suppressed for b6
by intrauterine exposure to maternal b4 anti-b6 antibodies, "neutralization" of
suppression could be achieved more readily by injecting b6 Ig which also had
antibody activity against b4 than by using b6 Ig without antibody activity
against the maternal allotype . They have attributed this superior neutralizing
capacity to antiallotypic precipitation "in two directions ." The neutralization of
suppression in b6-suppressed b4b6 neonates by b6 anti-b4 Ig and the reversal of
suppression in spleen cells of b4-suppressed b4b6 rabbits by b4 anti-b6 serum
seem on superficial inspection to have elements in common. In both sets of
conditions Ig of the suppressed type is being furnished, as well as antibody
activity against the nonsuppressed type, and in both cases the suppression-neu-
tralizing reagent would bind the maternal type antibody both as an antigen and
as an antibody. However, it should be kept firmly in mind that the spleen cells
used in the experiments described in this report were from suppressed rabbits up
to 8 mo of age, and that passively acquired maternal Ig is not detectable in the
serum of the offspring after the age of about 8 wk (1).3
Although in the examples documented here of reversal of b4 suppression by b4
anti-b6 (or b4 and anti-b6), there is an obvious double relationship between the
' In the interest ofsimplicity, in the remainder ofthe discussion the example ofb4-suppressed b4b6
cells will be used, although the same principles also apply to the b4b5 system.
' Dray's measurements are based on precipitation in agar gel. By the more sensitive HI test, traces
of maternal Ig are still found in the serum at 10-11 wk (F. L. Adler, unpublished observations) .LOUISE T. ADLER AND FRANK L. ADLER
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suppression-releasing combination and the maternal antibody which brought
about suppression, the longlasting nature of allotype suppression makes it
difficult to envision a role for maternal antibody in maintenance of thecondition.
If one discards the notion of a relevant and necessary role for maternal antibody
in the maintenance of chronic suppression, it is possible to explain the observed
results in the following manner: one would assume that most of the splenic
lymphocytes in a b4-suppressed b4b6 rabbit display b6 on their membranes.
Direct experimental evidence for this comes from the fluorescence studies of
Harrison et al. (11) and also from Sell's observation on blast transformation in
peripheral blood lymphocytes of allotype-suppressed rabbits (12) . Binding of
anti-b6 antibody by such cells could then initiate a series of events beginning
with capping and endocytosis of the antibody (13, 14), or endocytosis without
capping (15), leading to possible blast transformation (16) and depression of
specific Ig synthesis (17-20). Cells not displaying b6 Ig and thus potentially
producers of b4 Ig or their precursors would then proliferate. A variation of this
theory would propose that the b4-suppressed animal possesses precursor cells
that are potential producers of either b4 or b6 Ig, but which carry membrane b6.
The anti-b6 serum might then bring about simultaneous repression of b6 and
derepression of b4. Recent evidence obtained by Jones et al. (21), indicating that
in normal heterozygous rabbitsB lymphocytes marked with agivenmembrane Ig
are committedto differentiate into plasma cells capable of producingthat Ig type
would speak against this idea, but one cannot rule out the possibility that the
properties of lymphocytes from allotype-suppressed animals may differ from
those of normal animals in this respect. Similar hypotheses were first offered by
Dray (1) to explain the induction of allotype suppression in heterozygotes,
which is always accompanied by a compensatory increase in the product of the
alternate allele so that normal total Ig levels in the serum are maintained.
However, the results presented in Tables 11 and III clearly show that b4
suppression is not overcome by inhibition of b6 expression alone butalso requires
the presence of nonantibody b4 Ig, which in itself does not release suppression. A
possible role for this component could be that of providing a "priming" effect for
b4 production . Such a mechanism for regulation of Ig synthesis by feedback
control has been proposed by Mage et al. (22) to accountfor thesomewhat higher
levels of a given Ig type found in adult heterozygous rabbits when that type is
contributed by the maternal rather than by the paternal gene.
Alternatively, a completely different hypothesis to integrate the findings
reported here and in a previous publication (3) suggests itself ifthey areviewed in
terms of interference with a specific suppressive mechanism initiated by the
presence of antiallotype antibodies in prenatal or neonatal life. Jacobson,
Herzenberg et al . have presented evidence that chronic allotype suppression in
the mouse is an active process dependent on the activity of suppressor T cells in
the lymphoid system (23-25). Recently obtained evidence showing the transfer of
b4 suppression from lymphoid cells of b4-suppressed rabbits to normal b4 cells
indicates that an active suppression mechanism exists in allotype-suppressed
rabbits as well.' It would seem reasonable to propose that suppressor cells in the
' The specificity of this suppression is currently under investigation.342
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present model would have b6 Ig on their membranes and would therefore be
targets for inactivation by anti-b6. Although no direct cytotoxic effect of
antiallotypic antibodies has been demonstrated (26-28), Mage (2) has recently
discussed alternative mechanisms by which prolonged exposure to such anti-
bodies might lead to eventual cell inactivation or death. A number of investiga-
tors have studied the ability of antibodies directed against membrane-bound
antigens to interfere with the activity of such cells in the graft-vs .-host or the
mixed lymphocyte reactions (29-34). Where tested, the antisera used were shown
not to be cytotoxic. Such reports seem to be especially relevant to the current
discussion of suppressor cells, since they deal with known activities of lymphoid
cells against other lymphoid cells. Assuming, then, a restraining role of the
antiallotypic antibody upon the suppressor cell, one could once again assign to
the nonantibody b4 Ig the priming function that has been discussed earlier.
However, another role for b4 Ig becomes apparent if one considers the
likelihood that in a mechanism of allotype suppression involving the activity of
suppressor cells, a precursor cell beginning to differentiate into a b4-producing
cell would be the target for a suppressor cell with recognition for its identity as a
b4 cell. It is conceivable then that Ig marked with the b4 determinant might
compete with target cells for specific sites on suppressor cells involved in b4
suppression. In support of such a concept, Schirrmacher et al . (35) have
presented evidence for interference by free antigen with lymphoid cell activity
against antigen-coated target cells. However, since the data show that both
anti-b6 activity and the participation of normal b4 Ig are needed in order to bring
about release from b4 suppression, it becomes necessary to postulate that the
hypothetical suppressor cell must suffer "two hits" before becoming inoperative,
one against its b6 identity and the other against its receptor activity for
b4-labeled targets.
A different explanation for the failure of b5 anti-b6 to cause release from b4
suppression would require the assumption of cross-reactivity between antibodies
in such sera and b4. Thus, these antibodies might bind emerging b4 Ig or inhibit
cells that escape from b4 suppression, and the requirement for the addition of b4
Ig would be created by the need to neutralize these postulated cross-reactive
antibodies . We do not believe this explanation to be correct for a number of
reasons. Among these is our consistent failure to detect anti-b4 activity in b5
anti-b6 sera when using hemagglutination procedures that are not only highly
sensitive tests for antibody activity but also readily detect the known cross-reac-
tivity between b5 and b6 in antisera to b5 or b6 that were made in b4 rabbits.
Also speaking against this explanation, and possibly the strongest evidence
against it, is the observation that b6 anti-b5 serum effectively suppresses the b5
anti-T2 response of normal b4b5 spleen cells but totally lacks inhibitory activity
toward the b4 anti-T2 response of such cells (20) .
Continued investigation of the factors and conditions underlying the release
from allotype suppression in vitro using purified antibodies and normal globulins
may help to unravel the enigma of allotype suppression and to answer basic
questions concerning the control of Ig synthesis in normal animals. The
commonly observed "pecking order" among Ig allotypes in heterozygous normal
rabbits (i.e., b4 >b5 ; al >a2) suggests the possible occurrence of a controlThe authors wish to thank Mr. Raymond Harris, Mrs. Marsha Feldman, and Mr. Randolph Noelle for
skillful technical assistance during the course of this work, and also gratefully acknowledge the
excellent secretarial skills of Miss Katherine Kelly, who prepared the manuscript.
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mechanism similar in basis to that observed in allotype-suppressed animals (36).
Recent experimental evidence obtained by treating cultured spleen cells of
certain normal b4b5 rabbits with anti-b4 oranti-b5 serum more directlysupports
this concept (20).
Summary
Spleen cells of b4b6 rabbits, shown to bedeficient in their abilityto produce b4
Ig due to prenatal exposure toanti-b4, formed anti-T2 antibodies marked with the
b4 determinant in response to solubilized T2 phage (S-T2) only when cultured
in the presence of antibodies specific for the nonsuppressed type (b6), thus con-
firming and extending the previously reported observation of release from b4
suppression in cultured cells ofb4-suppressed b4b5 rabbits treated with anti-b5
serum. Only antiallotype sera made in b4 rabbits were active in reversingb4sup-
pression. Anti-b5 or anti-b6 sera from rabbits of allotypes b6 or b5, respectively,
when used in concentrations which completely or partiallyinhibitedthe formation
of anti-T2 antibodies marked with the corresponding nonsuppressed allotype of
the spleen donor, proved to be almost completely ineffective in causing release of
suppression. Exceptions were noted when spleen cellsofrabbitsadvanced inspon-
taneous escape from suppression were tested with such sera. The addition of
normal b4 serum to non-b4 antiallotypic sera rendered them as effective in
releasing b4 suppression in vitro as were antisera from b4 rabbits. Furthermore,
the capacity ofa b4 antiallotype serum to cause reversal of b4 suppression could
be potentiated by the addition ofnormal b4 serum, indicating that nonantibody
b4 Ig is a limiting factor in such a serum.
Thus, the release from allotype suppression observed in cultures ofspleen cells
from b4-suppressed heterozygous rabbits is dependent upon the presence oftwo
components: antibodies directed against the nonsuppressed allotype ofthe donor
and normal b4 Ig. These findings are interpreted in termsofalternate hypotheses
involving (a) a mechanism ofb4 derepression and (b) inactivation ofa suppressor
cell with recognition for a b4-labeled target .
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